Numeric Investors’s Pacific Biosciences PACB Stock Holding History

Numeric Investors’s Portfolio PACB Stock Details PACB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-89,700	Closed	-$804K	–	1141
2016 Q3	$804K	Sell	89,700 -349,800	-80%	-$2.92M	0.01%	668
2016 Q2	$3.09M	Buy	439,500 +365,900	+497%	+$3.34M	0.03%	375
2016 Q1	$626K	Buy	+73,600	New	+$724K	0.01%	651
2015 Q3	–	Sell	-233,552	Closed	-$1.34M	–	1111
2015 Q2	$1.34M	Sell	233,552 -698,965	-75%	-$4.04M	0.02%	449
2015 Q1	$5.45M	Buy	932,517 +783,517	+526%	+$5.4M	0.07%	244
2014 Q4	$1.17M	Buy	+149,000	New	+$953K	0.02%	430
2014 Q2	–	Sell	-54,600	Closed	-$292K	–	873
2014 Q1	$292K	Buy	54,600 +25,500	+88%	+$161K	0.01%	677
2013 Q4	$152K	Buy	+29,100	New	+$134K	﹤0.01%	741
2013 Q3	–	Sell	-18,200	Closed	-$46K	–	840
2013 Q2	$46K	Buy	+18,200	New	+$45.3K	﹤0.01%	758

Other funds holding PACB

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

Numeric Investors's PACB Position: Q4 2016 in Review

Numeric Investors sold out of Pacific Biosciences (PACB) in Q4 2016, closing a stake of 89,700 shares — an estimated $804K sold.

Numeric Investors first reported a position in PACB in Q2 2013 and held it in 9 quarters. The position peaked at $5.45M in Q1 2015. 115 funds tracked by Wall St. Rank hold PACB as of Q4 2016.

Numeric Investors reported no remaining Pacific Biosciences position as of Q4 2016 after selling out during the quarter.
Numeric Investors sold 89,700 Pacific Biosciences shares in Q4 2016, an estimated $804K.
Numeric Investors first reported a position in Pacific Biosciences in Q2 2013 and held it in 9 quarters.
Numeric Investors's Pacific Biosciences position peaked at $5.45M in Q1 2015.
115 funds tracked by Wall St. Rank held Pacific Biosciences as of Q4 2016.

Based on Numeric Investors's 13F filing for Q4 2016, filed 13 Feb 2017.